Symbiotec Pharmalab IPO listing gain & performance.
Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.
· data for the trading session of Wed 18 Nov 2026
Symbiotec Pharmalab IPO in brief
Written from NSE’s data, as of 18 Nov 2026.
Symbiotec Pharmalab came to the market at ₹988.00 a share (price band ₹938 to ₹988), with bidding open from 24 August to 27 August 2026. It listed on NSE on Tuesday, 1 September 2026, opening at ₹988.00, a gain of 0.0% on the issue price, and closed the first day +11.1% from the issue price after trading between -5.4% and +19.4%. 31% of the first day’s traded shares were taken for delivery.
The issue was subscribed 71.3× in total, institutions (QIB) 172×, HNIs (NII) 73.6×, retail investors 13.0×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.
Its listing gain beat 21% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 1 month after listing it was +21.3% from the issue price and +9.1% from the first-day close, while NIFTY 50 moved -6.8% over the same days. Its highest price so far was 69% above the issue price (16 Nov 2026) and its lowest 5% below it (1 Sep 2026); it closed below the issue price on 0% of the days since listing.
Share price since listing
Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.
Subscription
Times subscribed by investor group, NSE + BSE bids as reported by NSE.
For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.
Listing day
Tuesday 1 September 2026.
Returns after listing
Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.
| After listing | From issue price | From first-day close | NIFTY 50 | Median IPO (from issue) |
|---|---|---|---|---|
| 1 week8 Sep 2026 | +10.7% | -0.3% | -1.7% | +8.0% |
| 1 month1 Oct 2026 | +21.3% | +9.1% | -6.8% | +9.4% |
IPO details
From NSE’s issue page.
- Company
- Symbiotec Pharmalab
- NSE symbol
- SYMBIOTEC
- Board
- Main board
- Industry
- Pharmaceuticals
- Bidding
- 24 Aug – 27 Aug 2026
- Price band
- ₹938 to ₹988
- Issue price
- ₹988.00
- Issue size
- Initial Public Offer of Fresh Issue of Aggregating Up to Rs. 1,500 million and Offer for sale up to Rs. 16,070 million (Including Eligible Employees Reservation Portion of Aggregating up to Rs. 30 million and Anchor portion of 53,25,909 Equity shares)
- Bid lot
- 15 Equity Shares and in multiples thereof
- Listing date
- 1 September 2026
- ISIN
- INE899I01028
How all IPOs did after listing →IPO calendar →
Questions
What was the listing gain of the Symbiotec Pharmalab IPO?
What is the Symbiotec Pharmalab share price now against the IPO price?
How many times was the Symbiotec Pharmalab IPO subscribed?
When was the Symbiotec Pharmalab IPO open?
From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.
